Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review
Abstract Background Upper tract urothelial carcinoma (UTUC) is a rare subtype of urothelial cancer, accounting for only 5–10% of cases, and is characterized by aggressive biological behavior. Recent advances in immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) have expanded the...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2025-07-01
|
| Серии: | BMC Pulmonary Medicine |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12890-025-03838-z |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|